We need you! Join our contributor community and become a WikEM editor through our open and transparent promotion process.
Pneumonia (main)
From WikEM
								(Redirected from PNA)
												
				For pediatrics see pediatric pneumonia
Contents
Background
- Definition: infection of lung parenchyma
 - Empirically classified based upon location/risk factors
 
Health care–associated pneumonia risk factors
- Hospitalized for 2 or more days within past 90 days
 - Nursing home/long-term care residents
 - Receiving home IV antibiotics
 - Dialysis
 - Receiving chronic wound care
 - Receiving chemotherapy
 - Immunocompromised
 
Pseudomonas risk factors
- Alcoholism
 - Immunosuppression (including steroids)
 - Structural lung disease
 - Malnutrition
 - Recent antibiotics
 - Recent hospital stay
 
Causes of Pneumonia
Bacteria
Viral
- Common
- Influenza
 - Respiratory syncytial virus
 - Parainfluenza
 
 - Rarer
- Adenovirus
 - Metapneumovirus
 - Severe acute respiratory syndrome (SARS)
 - Middle east respiratory syndrome coronavirus (MERS)
 
 - Cause other diseases, but sometimes cause pneumonia
 
Fungal
- Histoplasmosis
 - Coccidioidomycosis
 - Blastomycosis
 - Pneumocystis jirovecii pneumonia (PCP)
 - Sporotrichosis
 - Cryptococcosis
 - Aspergillosis
 - Candidiasis
 
Parasitic
Commonly Encountered Pathogens by Risk Factor
| Risk Factor | Associated Organism | 
| Alcoholism | |
| COPD and/or Smoking | |
| Nursing Home | |
| Exposure to bird droppings | Histoplasma capsulatum | 
| Exposure to birds | Chlamydophila psittaci | 
| Exposure to rabbits | Francisella tularensis | 
| Exposure to farm animals | Coxiella burnetii (Q fever) | 
| Exposure to southwestern US | Coccidiomycosis (Valley fever) | 
| Early HIV | |
| Late HIV (as above, plus:) | |
| Aspiration | Anaerobes | 
| Structural Lung Disease (CF, bronchiectasis) | |
| Injection drug use | |
| Influenza | 
  | 
| Ventilator Associated Pneumonia | 
Clinical Features
- Fever, chills, pleuritic chest pain, productive cough
- Fever is seen in 80%
 
 - Tachypnea
- Most sensitive sign in elderly
 
 - Abdominal pain, nausea and vomiting, diarrhea may be seen with Legionella infection
 - Myalgia, fatigue
 
Differential Diagnosis
Shortness of breath
Emergent
- Pulmonary
- Airway obstruction
 - Anaphylaxis
 - Aspiration
 - Asthma
 - Cor pulmonale
 - Inhalation exposure
 - Noncardiogenic pulmonary edema
 - Pneumonia
 - Pneumocystis Pneumonia (PCP)
 - Pulmonary embolism
 - Pulmonary hypertension
 - Tension pneumothorax
 - Idiopathic pulmonary fibrosis acute exacerbation
 
 - Cardiac
 - Other Associated with Normal/↑ Respiratory Effort
 - Other Associated with ↓ Respiratory Effort
 
Non-Emergent
- ALS
 - Ascites
 - Uncorrected ASD
 - Congenital heart disease
 - COPD exacerbation
 - Fever
 - Hyperventilation
 - Neoplasm
 - Obesity
 - Panic attack
 - Pleural effusion
 - Polymyositis
 - Porphyria
 - Pregnancy
 - Rib fracture
 - Spontaneous pneumothorax
 - Thyroid Disease
 
Evaluation
- CXR
 - CBC
 - Chemistry
 
If patient will be admitted:
- Blood Cultures are ONLY indicated for CAP patients with:
- ICU (required)
 - Multi-lobar
 - Pleural effusion
 - Consider for higher-risk patients admitted with CAP 
- Liver disease
 - Immunocompromised
 - Significant comorbidities
 - Other risk factors
 
 
 - Sputum staining 
- If concern for particular organism
 
 
Chest X-Ray Mimics
- Malignancy
 - Tuberculosis
 - Pulmonary embolism - Hampton's hump
 - Atelectasis
 - ARDS
 - Diffuse alveolar hemorrhage
 - Multiple "cannonball" infiltrates
- Metastatic disease
 - Septic emboli
 - Right sided endocarditis
 
 
Management
Outpatient
Coverage targeted at S. pneumoniae, H. influenzae. M. pneumoniae, C. pneumoniae, and Legionella
Healthy
- Clarithromycin XL 1000mg PO QD x7d OR
 - Azithromycin 500mg PO day 1, 250mg on days 2-5 OR
 - Doxycycline 100mg BID x 10-14d (2nd line choice)
 
Unhealthy
Chronic heart, lung, liver, or renal disease; DM, alcholism, malignancy.
- Levofloxacin 750mg QD x5d OR
 - Moxifloxacin 400mg QD x7-14d OR
 - Amoxicillin/Clavulanate 2g BID AND
- Azithromycin 500mg day 1, 250mg days 2-5 OR
 - Doxycycline 100mg PO BID x 7-10 days OR
 - Clarithromycin 500mg PO BID x 7-10 days
 
 
Inpatient
- Monotherapy or combination therapy is acceptable. Combination therapy includes a cephalosporin and macrolide targeting atypicals and Strep Pneumonia [1]
 - The use of adjunctive corticosteroids (methylprednisolone 0.5 mg/kg IV BID x 5d) in CAP of moderate-high severity (PSI Score IV or V; CURB-65 ≥ 2) is associated with:[2]
- ↓ mortality (3%)
 - ↓ need for mechanical ventilation (5%)
 - ↓ length of hospital stay (1d)
 
 
Community Acquired (Non-ICU)
Coverage against community acquired organisms plus M. catarrhalis, Klebsiella, S. aureus
- Levofloxacin 750mg IV/PO once daily OR
 - Moxifloxacin 400mg IV/PO once daily OR
 - Ceftriaxone 1g IV once daily PLUS
- Azithromycin 500mg IV/PO once daily OR
 - Doxycycline 100mg IV/PO BID
 
 
Hospital Acquired or Ventilator Associated Pneumonia
- 3-drug regimen recommended options:
- Cefepime 1-2gm q8-12h OR ceftazidime 2gm q8h + Levofloxacin 750 mg PO/IV every 24 hours + Vancomycin 15mg/kg q12 OR
 - Imipenem 500mg q6hr + cipro 400mg q8hr + vanco 15mg/kg q12 OR
 - Piperacillin-Tazobactam 4.5gm q6h + cipro 400mg q8h + vanco 15mg/kg q12
 
 - Consider tobramycin in place of fluoroquinolones given FDA 2016 warnings
 
Ventilator Associated Pneumnoia
- High Risk of MRSA: Use 3-Drug Regimen. Several options are available, but recommendation is to include an antibiotic from each of these categories:[3]
- 1. MRSA Antibiotic: Vancomycin 15mg/kg q12h OR Linezolid 600 mg IV q12h PLUS
 - 2. Antipseudomonal Antibiotic: Piperacillin-Tazobactam 4.5gm q6h OR Cefepime 2 g IV q8h OR Imipenem 500 mg IV q6h OR Aztreonam 2 g IV q8h PLUS
 - 3. GN Antibiotic With Antipseudomonal Activity: Cipro 400 mg IV q8h
 
 
ICU, low risk of pseudomonas
- Ceftriaxone 1gm IV and Azithromycin 500mg IV OR
 - Ceftriaxone 1gm IV and (moxifloxacin 400mg IV or levofloxacin 750mg IV)
 - Penicillin allergy
- (Moxifloxacin or levofloxacin) + (aztreonam 1-2gm IV or clindamycin 600mg IV)
 
 
ICU, risk of pseudomonas
- Cefipime, Imipenem, OR Piperacillin/Tazobactam + IV cipro/levo
 - Cefipime, imipenem, OR piperacillin-tazobactam + gent + azithromycin
 - Cefipime, imipenem, OR piperacillin-tazobactam + gent + cipro/levo
 
References
- ↑ Chokshi R, Restrepo MI, Weeratunge N, Frei CR, Anzueto A, Mortensen EM. Monotherapy versus combination antibiotic therapy for patients with bacteremic Streptococcus pneumoniae community-acquired pneumonia. Eur J Clin Microbiol Infect Dis. Jul 2007;26(7):447-51
 - ↑ Siemieniuk RA, Meade MO, Alonso-Coello P, Briel M, Evaniew N, Prasad M, Alexander PE, Fei Y, Vandvik PO, Loeb M, Guyatt GH. Corticosteroid Therapy for Patients Hospitalized With Community-Acquired Pneumonia: A Systematic Review and Meta-analysis. Ann Intern Med. Aug 11, 2015
 - ↑ Kalil AC, Metersky ML, Klompas M et al. Management of Adults With Hospital-acquired and Ventilator-associated Pneumonia: 2016 Clinical Practice Guidelines by the Infectious Diseases Society of America and the American Thoracic Society. Clin Infect Dis. 2016 Sep 1;63(5):e61-e111.
 
Disposition
Pneumonia severity index (Port Score)
| 
 Risk Factors  | 
 Points | 
|  Demographic Factors  | |
|  Age for men | 
 Age | 
|  Age for women | 
 Age -10 | 
|  Nursing home resident | 
 +10 | 
|  Coexisting Illnesses  | 
  | 
|  Neoplastic disease (active) | 
 +30 | 
|  Chronic liver disease | 
 +20 | 
|  Heart Failure | 
 +10 | 
|  Cerebrovascular disease | 
 +10 | 
|  Chronic renal disease | 
 +10 | 
|  Physical Exam  | 
  | 
|  AMS | 
 +20 | 
|  RR > 30/min | 
 +20 | 
|  Sys BP < 90 | 
 +20 | 
|  Temp <35 or >40 | 
 +15 | 
|  Pulse > 125 | 
 +10 | 
|  Lab and xray findings | 
  | 
|  Arterial pH < 7.35 | 
 +30 | 
|  BUN > 30 | 
 +20 | 
|  Na <130 | 
 +20 | 
|  Glucose > 250 | 
 +10 | 
|  Hematocrit <30% | 
 +10 | 
|  PaO2 < 60 or SpO2 < 90% | 
 +10 | 
|  Pleural effusion | 
 +10 | 
Classification
|  Class  | 
 Points  | 
 Mortality  | 
|  I | 
<51 |  0.1% | 
|  II | 
51-70 |  0.6% | 
|  III | 
 71-90 | 
 0.9% | 
|  IV | 
 91-130 | 
 9.3% | 
|  V | 
 >130 | 
 27% | 
Disposition Pathway
- Classes I and II: consider discharge
 - Class III: discharge verus admit based on clinical judgment
 - Classes IV and V: consider admission
 
CURB-65
- Confusion
 - bUn > 19 mg/dl
 - RR > 30
 - BP < 90 SBP, or < 60 DBP
 - Age > 65
 
- Approximate 30-day mortalities and Tx considerations
- +1 --> 3%, outpt tx
 - +2 -->7%, inpt, possible outpt
 - +3 --> 14% inpt, possible ICU
 - +4-5 --> 30% ICU
 
 

